Literature DB >> 5104003

Maturation of convulsogenic activity induced by leptazol in the albino rat.

M de Casrilevitz, E Engelhardt, C A Esbérard.   

Abstract

1. Maturation of the excitatory and inhibitory neuromechanisms at various levels of the central nervous system was demonstrated by the convulsogenic activity induced by leptazol in the developing albino rat.2. The somatomotor end points considered (myoclonic jerk, myoclonic seizure, tonic seizure and catalepsy) were not observed in all age groups. Tonic seizure was seen at birth, myoclonic jerks at 2 weeks of age, myoclonic seizure and catalepsy at 3 weeks of age.3. The convulsive sequences described presented three different patterns, defining three age groups: the infant pattern (infant group: newborn-1 week old animals); the transitional pattern (transitional group: 2 week old animals); and the adult pattern (adult group: 3 week old-adult animals).4. Effective doses were determined for the three types of convulsive sequence: MJ50 for the myoclonic major sequence (maximal end point: myoclonic jerk), MS50 for the myoclonic major sequence (maximal end point: myoclonic seizure) and the TS50 for the myoclonic-tonic-clonic sequence (maximal end point: tonic seizure).5. The correlation of the convulsive patterns with the dose and latency variations suggests that: (a) the neuromechanisms responsible for the tonic seizure and clonic seizure, located at brainstem and spinal cord levels, function at birth and reach maturity at 3 weeks of age; (b) the neuromechanisms responsible for the myoclonic manifestations and for catalepsy, located at the striato-thalamocortical level, start functioning at 2-3 weeks of age, indicating the later maturation of the more cephalic structures.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5104003      PMCID: PMC1666994          DOI: 10.1111/j.1476-5381.1971.tb07084.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Megimide and metrazol; a comparison of their convulsant properties in man and cat.

Authors:  E A RODIN; L T RUTLEDGE; H D CALHOUN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1958-11

2.  Analysis of the spinal excitatory action of pentylenetetrazol.

Authors:  J LEWIN; D W ESPLIN
Journal:  J Pharmacol Exp Ther       Date:  1961-05       Impact factor: 4.030

3.  Physiological and pharmacological analysis of spinal cord convulsions.

Authors:  D W ESPLIN; J W FRESTON
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

4.  Effect of metrazol on cortical and subcortical evoked potentials.

Authors:  T OKUMA
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1960-08

5.  Effects of diphenylhydantoin on synaptic transmission in cat spinal cord and stellate ganglion.

Authors:  D W ESPLIN
Journal:  J Pharmacol Exp Ther       Date:  1957-07       Impact factor: 4.030

6.  [Neurophysiopathological aspects of catatonia].

Authors:  C MATTIOLI-FOGGIA; M COSSIO
Journal:  Riv Patol Nerv Ment       Date:  1957

7.  Determinants of flexor and extensor components of maximal seizures in cats.

Authors:  D W ESPLIN; R J LAFFAN
Journal:  Arch Int Pharmacodyn Ther       Date:  1957-12-01

8.  [Bulbocapnine catatonia, its synergists and antagonists].

Authors:  G ZETLER; E MOOG
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

9.  Effect of metrazol and nembutal on motor activity in the spinal cat.

Authors:  D P Jones; C T Lombroso
Journal:  Am J Physiol       Date:  1955-01

10.  The convulsive patterns provoked by indoklon, metrazol and electroshock: some depth electrographic observations in human patients.

Authors:  G E CHATRIAN; M C PETERSEN
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1960-08
View more
  4 in total

1.  Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.

Authors:  Catherine Kulick; Samuel Gutherz; Alexei Kondratyev; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-06-23       Impact factor: 4.432

2.  Pentylenetetrazol-induced seizures in rats: an ontogenetic study.

Authors:  L Velisek; H Kubova; M Pohl; L Stankova; P Mares; R Schickerova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

3.  Effect of alpha-hexachlorocyclohexane on the convulsive activity of pentetrazol (Cardiazol) in the rat.

Authors:  H W Vohland; W Koransky; H Zufelde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.

Authors:  Pavel Mares; Grygoriy Tsenov; Hana Kubova
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.